Surgery in recurrent ovarian cancer: The SOCceR trial.
Suspended
- Conditions
- Ovarian cancerPlatinum sensitive RecurrenceCytoreductive surgery/debulkingOvariumcarcinoomPlatinum sensitiefRecidiefCytoreductieve chirurgie/debulking
- Registration Number
- NL-OMON20627
- Lead Sponsor
- Radboud University Nijmegen Medical Centre
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 230
Inclusion Criteria
1. Age ≥ 18 years;
2. First recurrence of histologically or cytologically proven epithelial ovarian cancer, primaryperitoneal cancer or fallopian tube cancer of FIGO stage Ic-IV (FIGO system 1988);
Exclusion Criteria
1. Participation in interfering trial;
2. Non-epithelial or borderline ovarian tumours;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival.
- Secondary Outcome Measures
Name Time Method 1. Overall survival;<br /><br>2. Quality of life;<br /><br>3. Tumor response;<br /><br>4. Peri-operative morbidity and mortality.